Fig. 2.

(A) Bubble plot comparing the population, actual number of COVID-19 cases and the genome sequencing data (per 1000 cases) deposited in the GISAID database for major countries around the globe. (B) Map comparing the genome sequencing data (per 1000 cases) deposited in the GISAID database across the globe. Developed countries such as United States, United Kingdom and Australia (marked in blue) have the maximum contribution to genomic surveillance while developing nations in Asia and Africa lag well behind (marked in light green). (C) Plot showing the relative contribution of various countries to genomic surveillance, prevalence of disease and the median days to deposition to the GISAID database. India (yellow line) is in the lower part of the curve (far left) in terms of genomic sequencing reflecting poor genomic surveillance however, is ranked second just behind the US (blue line) in terms of absolute number of cases. (Fig. 2A,2B,2C source: COVID CoV Genomics (CG); Available at: covidcg.org) .⁶